person · Reporting owner
Edwards Carladenise Armbrister
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Director | May 18, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date May 18, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 285,432 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Sale · Disposed 67,160 · Balance 285,432 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 19, 2026 21:32 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 67,160 | $3.42 | $229,687.20 |
DisclosureSEC source: 0001801170-26-000131 · wk-form4_1779226357.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,432 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 79,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-26-000009 · wk-form4_1767906672.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,592 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:12 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | SaleClass A Common Stock | 200,000 | $3.61 | $722,000.00 |
DisclosureSEC source: 0001801170-25-000068 · wk-form4_1741723964.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,227 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.54 to $3.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000019 · wk-form4_1736373009.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,227 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:26 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 206,185 | $0.97 | $199,999.45 |
DisclosureSEC source: 0001801170-24-000027 · wk-form4_1704489990.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 412,252 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 3, 2024, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:31 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 176,991 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000464 · wf-form4_167295423886671.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,067 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 3, 2023, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:02 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 20,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025508 · wf-form4_166422970848030.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,076 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSU"). One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 20:26 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 8,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001937412-22-000008 · wf-form4_165886719563485.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,805 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on September 22, 2022, the date of the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service as a member of the Board through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.